Interestingly, we found that level of NANOG-responsive genes and HSP90AA1 within tumor inversely correlated with T cell infiltration in various cancer patients from TCGA (Supplementary Fig. 19), suggesting NANOG–HSP90A axis in tumor cells induces ICB therapeutic resistance. The gene discussed is HSP90AA1; the disease is neoplasm.